Principles and Practice of Pharmaceutical Medicine

variety of nonharmonized risk management programs. Similarly, sertindole. In this case, the marketing authorization for this ant ...

Stang PE, Gardner J. 2005. ‘Epidemiology and pharma- coeconomic research’. InPrinciples of Pharmacoe- conomics, Bootman JL, Town ...

...

42 Publishing Clinical Studies Anthony W. Fox 42.1 Introduction This chapter has three objectives. First, it is neces- sary to d ...

publications, and nor do they belong in regulatory documents or marketing materials. Omissions of details in methods and results ...

later the same negative result. Chalmers (1990), somewhat hyperbolically, has actually character- ized underreporting of clinica ...

pen to paper, and judge whether the quantity of material supports a whole paper, a brief report or even more than one paper. Aut ...

can be published in the small spaces of isolated abstracts and posters. Audiovisual presentations at academic meetings It is ama ...

up’. Practice showing one slide before wrongly loading all of them. (j) Relate the middle part of your talk to your take-home me ...

Press releases Pharmaceutical physicians in large pharmaceutical companies will only very rarely be exposed to the need for pres ...

manuscripts from federal employees cannot be claimed as proprietary because their work product is deemed always to belong to the ...

Skelton J. 1994. ‘Analysis of the structure of original research papers: an aid to writing original papers for publication’.Br. ...

...

43 Organizing and Planning Local, Regional, National and International Meetings and Conferences Zofia DziewanowskaandLinda Packa ...

best: they will know the management of the facility itself, as well as the potential for local tours, activ- ities and so on. Th ...

(in the United States) sporting events, and accom- modations in even small hotels may be unavailable or highly expensive. When t ...

morale, and, if you can retain them, make next year’s conference easier. In summary, large meetings are tough and time consuming ...

44 Drug Withdrawals From the Market – Causes and Consequences Ronald D. Mann 44.1 Introduction From the point of view of a pharm ...

final report, to make the following quite remark- able statement: ‘No drug which is pharmacologically effective is entirely with ...

developed world. The fundamentals are given in theGuidance for Industry – Good Pharmacovigi- lance Practices and Pharmacoepidemi ...